GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in Infantile Spasms (IS) – Orphan Drug Designation Granted from FDA for Epidiolex for the Treatment of IS – ...read more
Growth Capitalist (https://growthcapitalist.com/2016/06/gw-pharma-epidiolex-gains-4th-orphan-drug-designation/)
GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in Infantile Spasms (IS) – Orphan Drug Designation Granted from FDA for Epidiolex for the Treatment of IS – ...read more